Drug Discovery and Development Analysis & Statistics, January 2013 (p35)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: clinical trial, drug discovery, drug development, more »

1021-1060 of about 2 800 reports

Purchase Reports From Reputable Market Research Publishers

H 2 Antagonist -Pipeline Insights, 2014

H 2 Antagonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“H 2 Antagonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
H 3 Antagonist -Pipeline Insights, 2014

H 3 Antagonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“H 3 Antagonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
H 4 Antagonist -Pipeline Insights, 2014

H 4 Antagonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“H 4 Antagonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
Hepcidin Antagonist -Pipeline Insights, 2014

Hepcidin Antagonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hepcidin Antagonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
HIF-1 Alpha Inhibitors -Pipeline Insights, 2014

HIF-1 Alpha Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“HIF-1 Alpha Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Histamine Receptors Antagonists -Pipeline Insights, 2014

Histamine Receptors Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Histamine Receptors Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Histone Deacetylase 1 (HDAC1) Inhibitors -Pipeline Insights, 2014

Histone Deacetylase 1 (HDAC1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Histone Deacetylase 1 (HDAC1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Histone Deacetylase 1 (HDAC8) Inhibitors -Pipeline Insights, 2014

Histone Deacetylase 1 (HDAC8) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Histone Deacetylase 1 (HDAC8) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Histone Deacetylase 2 (HDAC2) Inhibitors -Pipeline Insights, 2014

Histone Deacetylase 2 (HDAC2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Histone Deacetylase 2 (HDAC2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Histone Deacetylase 3 (HDAC3) Inhibitors -Pipeline Insights, 2014

Histone Deacetylase 3 (HDAC3) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Histone Deacetylase 3 (HDAC3) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Histone Deacetylase 6 (HDAC6) Inhibitors -Pipeline Insights, 2014

Histone Deacetylase 6 (HDAC6) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Histone Deacetylase 6 (HDAC6) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
HIV Attachment Inhibitor -Pipeline Insights, 2014

HIV Attachment Inhibitor -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“HIV Attachment Inhibitor-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
HIV Protease Inhibitors -Pipeline Insights, 2014

HIV Protease Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“HIV Protease Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
HIV-1 Protease (HIV-1 PR) Inhibitors -Pipeline Insights, 2014

HIV-1 Protease (HIV-1 PR) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“HIV-1 Protease (HIV-1 PR) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
HIV-2 Protease (HIV-2 PR) Inhibitors -Pipeline Insights, 2014

HIV-2 Protease (HIV-2 PR) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“HIV-2 Protease (HIV-2 PR) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitors -Pipeline Insights, 2014

Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug Discovery and Development
Hypoxia Inducible Factor (HIF) Inhibitors -Pipeline Insights, 2014

Hypoxia Inducible Factor (HIF) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hypoxia Inducible Factor (HIF) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Hypoxia Inducible Factor Prolyl-4-Hydroxylase (HIF-PH) Inhibitors -Pipeline Insights, 2014

Hypoxia Inducible Factor Prolyl-4-Hydroxylase (HIF-PH) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hypoxia Inducible Factor Prolyl-4-Hydroxylase (HIF-PH) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug Discovery and Development
IkappaB Kinase (IKK) Inhibitors -Pipeline Insights, 2014

IkappaB Kinase (IKK) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IkappaB Kinase (IKK) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
IL-1 Alpha Inhibitors -Pipeline Insights, 2014

IL-1 Alpha Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-1 Alpha Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
IL-1 Receptor Antagonists -Pipeline Insights, 2014

IL-1 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-1 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
IL-13 Receptor Antagonists -Pipeline Insights, 2014

IL-13 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-13 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
IL-17 Receptor Antagonists -Pipeline Insights, 2014

IL-17 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-17 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
IL-8 Receptor Antagonists -Pipeline Insights, 2014

IL-8 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-8 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
IL-23 Receptor Antagonists -Pipeline Insights, 2014

IL-23 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-23 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
IL-4 Receptor Antagonists -Pipeline Insights, 2014

IL-4 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-4 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
IL-6 Receptor Antagonists -Pipeline Insights, 2014

IL-6 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“IL-6 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitors -Pipeline Insights, 2014

Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Inducible Nitric Oxide Synthase (iNOS or Type II NOS) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Drug Discovery and Development
Inhibitors of Apoptosis (IAP) Antagonists -Pipeline Insights, 2014

Inhibitors of Apoptosis (IAP) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Inhibitors of Apoptosis (IAP) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Drug Discovery and Development
Inosine 5%-Monophosphate Dehydrogenase 1 (IMPDH-1) Inhibitors -Pipeline Insights, 2014

Inosine 5%-Monophosphate Dehydrogenase 1 (IMPDH-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Inosine 5'-Monophosphate Dehydrogenase 1 (IMPDH-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Drug Discovery and Development

83 Companies

Read our Company Profiles

Pfizer Inc.

United States

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.